ArticleEuropean journal of cancer (Oxford, England : 1990)2025

Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023).

Giovanni Maria Iannantuono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.